AU2014294983B2 - Imaging neurological disease - Google Patents

Imaging neurological disease Download PDF

Info

Publication number
AU2014294983B2
AU2014294983B2 AU2014294983A AU2014294983A AU2014294983B2 AU 2014294983 B2 AU2014294983 B2 AU 2014294983B2 AU 2014294983 A AU2014294983 A AU 2014294983A AU 2014294983 A AU2014294983 A AU 2014294983A AU 2014294983 B2 AU2014294983 B2 AU 2014294983B2
Authority
AU
Australia
Prior art keywords
imaging
radiopharmaceutical
normal
ratio
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014294983A
Other languages
English (en)
Other versions
AU2014294983A1 (en
Inventor
Mark Joseph Rosser
Jan Wolber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of AU2014294983A1 publication Critical patent/AU2014294983A1/en
Priority to AU2019253837A priority Critical patent/AU2019253837B2/en
Application granted granted Critical
Publication of AU2014294983B2 publication Critical patent/AU2014294983B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
AU2014294983A 2013-07-25 2014-07-25 Imaging neurological disease Active AU2014294983B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2019253837A AU2019253837B2 (en) 2013-07-25 2019-10-23 Imaging neurological disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
GB1313291.5 2013-07-25
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019253837A Division AU2019253837B2 (en) 2013-07-25 2019-10-23 Imaging neurological disease

Publications (2)

Publication Number Publication Date
AU2014294983A1 AU2014294983A1 (en) 2016-01-21
AU2014294983B2 true AU2014294983B2 (en) 2019-10-24

Family

ID=49166921

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014294983A Active AU2014294983B2 (en) 2013-07-25 2014-07-25 Imaging neurological disease
AU2019253837A Active AU2019253837B2 (en) 2013-07-25 2019-10-23 Imaging neurological disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019253837A Active AU2019253837B2 (en) 2013-07-25 2019-10-23 Imaging neurological disease

Country Status (16)

Country Link
US (1) US11051777B2 (enExample)
EP (1) EP3024501B1 (enExample)
JP (1) JP6590801B2 (enExample)
KR (1) KR102340504B1 (enExample)
CN (1) CN105392500B (enExample)
AU (2) AU2014294983B2 (enExample)
BR (1) BR112016001316B1 (enExample)
CA (1) CA2916125A1 (enExample)
DK (1) DK3024501T3 (enExample)
ES (1) ES2722973T3 (enExample)
GB (1) GB201313291D0 (enExample)
IL (1) IL243383B (enExample)
MX (1) MX2016001012A (enExample)
RU (1) RU2015155792A (enExample)
SG (1) SG11201600571RA (enExample)
WO (1) WO2015011267A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
US20180000440A1 (en) * 2015-03-24 2018-01-04 Nihon Medi-Physics Co., Ltd. Image processing apparatus, image processing method, and program
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Ｓｐｅｃｔ多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) * 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
US20230001026A1 (en) * 2019-11-21 2023-01-05 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
AR125188A1 (es) 2021-03-22 2023-06-21 Neurocrine Biosciences Inc Inhibidores del vmat2 y métodos de uso
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040727A2 (en) * 2007-09-26 2009-04-02 Philips Intellectual Property & Standards Gmbh Method of differentially diagnosing different types of dementia
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
US20100312105A1 (en) * 2007-10-31 2010-12-09 Alseres Pharmaceuticals, Inc. Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Hsiao, MC et al (2003) Schizophrenia Research 65: 39-46 *
Katzenschlager,R et al (2003) Ann Neurol 53: 489-496 *
Seibyl, JP et al (1995) Ann Neurol 38: 589-598 *

Also Published As

Publication number Publication date
CN105392500B (zh) 2023-08-18
WO2015011267A1 (en) 2015-01-29
IL243383B (en) 2018-07-31
RU2015155792A3 (enExample) 2018-05-23
CA2916125A1 (en) 2015-01-29
US11051777B2 (en) 2021-07-06
GB201313291D0 (en) 2013-09-11
AU2014294983A1 (en) 2016-01-21
RU2015155792A (ru) 2017-08-30
JP6590801B2 (ja) 2019-10-16
HK1222118A1 (zh) 2017-06-23
ES2722973T3 (es) 2019-08-20
KR102340504B1 (ko) 2021-12-20
EP3024501A1 (en) 2016-06-01
KR20160037168A (ko) 2016-04-05
EP3024501B1 (en) 2019-03-27
DK3024501T3 (da) 2019-05-06
BR112016001316B1 (pt) 2021-04-06
US20160183897A1 (en) 2016-06-30
SG11201600571RA (en) 2016-02-26
JP2016531903A (ja) 2016-10-13
AU2019253837A1 (en) 2019-11-14
AU2019253837B2 (en) 2021-11-25
CN105392500A (zh) 2016-03-09
MX2016001012A (es) 2016-05-09

Similar Documents

Publication Publication Date Title
AU2019253837B2 (en) Imaging neurological disease
Guedj et al. EANM procedure guidelines for brain PET imaging using [18F] FDG, version 3
Villemagne et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
Politis et al. Positron emission tomography imaging in neurological disorders
Henry et al. In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy
Zhu et al. PET/SPECT imaging agents for neurodegenerative diseases
Gerhard et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Choe et al. Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden
Mountz et al. Comparison of qualitative and quantitative imaging characteristics of [11C] PiB and [18F] flutemetamol in normal control and Alzheimer's subjects
Nocker et al. Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I] β-CIT SPECT
Gulyás et al. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C] vinpocetine
Masterman et al. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias
Eusebio et al. Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects
Ryding et al. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy
Hsiao et al. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients
Molina et al. Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity
JP2011502966A (ja) ドーパミントランスポーターレベルを評価することによるレビー小体型認知症の診断およびレビー小体型認知症の処置のモニタリングのための方法
JP2014148529A (ja) ドーパミン輸送体レベルを造影するための方法
CN104718299B (zh) 用于线粒体复合物i的定量定位的系统和方法
Nobler et al. Cerebral blood flow and metabolism in late-life depression and dementia
Varrone et al. Molecular imaging of neuroinflammation in Alzheimer’s disease
Edison et al. Strategies for the generation of parametric images of [11C] PIB with plasma input functions considering discriminations and reproducibility
Caroli et al. Quantitative evaluation of Alzheimer’s disease
HK1222118B (zh) 成像神经学疾病
Khattar et al. Optimized reference region and the effect on test-retest reliability and detection of Parkinson’s disease with [11C] UCB-J

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)